TB advocates urge pharmaceutical companies to register their respective linezolid products in South Africa and make them available at an affordable price.

The targets set forth in the Obama Administration’s National Action Plan for Combating Multidrug-Resistant Tuberculosis are not ambitious enough to effectively stop the spread of multidrug-resistant tuberculosis.

The White House released a comprehensive action plan identifying a set of targeted interventions that address the core domestic and global challenges posed by multidrug-resistant and extensively drug-resistant tuberculosis.

The petition will be open for signatures until World TB Day, March 2016, when it will be presented to world leaders.

Let's Talk TB is a book on the current best practices for TB diagnosis and treatment for all general and private practitioners in India and other high-burden countries.

The guide serves as a framework for activists in Southern and East Africa working on HIV, TB and human rights issues in the region. It aims to provide a starting point for activists to identify the key advocacy priorities relating to TB and human rights in their own countries.

The World Health Organization report presents the latest data and in-depth analysis for the key areas outlined in the health Sustainable Development Goals, including tuberculosis.

The Lancet Series on how to eliminate tuberculosis is a response to the fact that business as usual can no longer be an option in the fight against tuberculosis. Four Series papers address changes in the current strategy that will be necessary to achieve zero deaths from tuberculosis, and to reach 2050 elimination targets in high-burden settings.

The Global Fund prepared a toolkit to help partners implement differentiated care approaches in HIV and TB investments with the aim of maximizing cost efficiency and better serving the different needs of various communities most affected by diseases.

TB activists at the 46th Union World Conference on Lung Health demanded that pharmaceutical company Sanofi be held accountable for failing to provide life-saving products to people and children living with TB and drug-resistant TB in South Africa and across the world.